Century Therapeutics
IPSC
100 hedge funds and large institutions have $387M invested in Century Therapeutics in 2026 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 10 closing their positions.
508% more capital inflows, than outflows
Capital inflows: $52.7M | Capital outflows: $8.66M
280% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 10
142% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 12
65% more call options, than puts
Call options by funds: $543K | Put options by funds: $330K
39% more funds holding
Funds holding: 72 → 100 (+28)
10.41% more ownership
Funds ownership: 77.2% → 87.61% (+10%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15M |
| 2 |
SC
Stempoint Capital
New York
|
+$4.9M |
| 3 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
+$3.85M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.83M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Syncona Portfolio
St Peter Port,
Guernsey
|
-$2.74M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.25M |
| 3 |
Millennium Management
New York
|
-$1.08M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$627K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$310K |
IPSC Hedge Fund Activity: Q2 2026 in Review
100 of the 8,354 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q2 2026, worth a combined $387M — up 24% from $312M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new IPSC positions and 10 closed out — a net gain of 28 holders — while 29 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $15M. The largest seller was Syncona Portfolio, exiting entirely with an estimated $2.74M sold.
- 100 institutional investors held Century Therapeutics (IPSC) as of Q2 2026, up from 72 in Q1 2026.
- Funds reported $387M of Century Therapeutics stock for Q2 2026, up 24% quarter-over-quarter.
- 38 funds opened new Century Therapeutics positions in Q2 2026 and 10 closed out, a net change of +28 holders.
- The largest Century Therapeutics buyer in Q2 2026 was BlackRock, an estimated $15M added.
- The largest Century Therapeutics seller in Q2 2026 was Syncona Portfolio, an estimated $2.74M sold.
Based on aggregated 13F filings for Q2 2026.